Target intelligence / Profile preview

Peripheral Insulin Sensitivity Pathway

Molecular classification
Signaling Pathway, Metabolic Pathway
01

Overview

The peripheral insulin sensitivity pathway refers to the molecular and cellular mechanisms by which insulin regulates glucose uptake and metabolism in peripheral tissues, primarily skeletal muscle, adipose tissue, and liver. This pathway involves a cascade of events starting with insulin binding to its receptor, leading to downstream signaling through IRS proteins, PI3K, Akt, and ultimately, GLUT4 translocation to the cell membrane for glucose uptake. Impairment of this pathway contributes to peripheral insulin resistance, a hallmark of metabolic disorders like type 2 diabetes and obesity.

Other names
Insulin Signaling Pathway (Peripheral Tissues)Insulin Resistance Pathway (Peripheral Tissues)Glucose Uptake Pathway (Peripheral Tissues)
02

Mechanism of action

Various, depending on the specific target within the pathway. Examples: Metformin enhances insulin sensitivity; Thiazolidinediones activate PPARγ, improving insulin sensitivity.

03

Biological functions

Glucose uptakeGlucose metabolismSignal transductionInsulin signalingGlycogen synthesis
04

Disease associations

Type 2 Diabetes MellitusObesityInsulin ResistanceMetabolic Syndrome
05

Safety considerations

Hypoglycemia (with insulin or insulin secretagogues)Weight gain (with thiazolidinediones)Cardiovascular risks (historical concerns with some thiazolidinediones)Liver toxicity (rare with some antidiabetic drugs)
06

Interacting drugs

Metformin

3 more in the full profile.

07

Biomarkers

Fasting glucose levelsHbA1cInsulin levelsHOMA-IR (Homeostatic Model Assessment for Insulin Resistance)Adiponectin levels

Beyond the preview

Go deeper on Peripheral Insulin Sensitivity Pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral Insulin Sensitivity Pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call